Lifeward Ltd. (LFWD)

Market Cap	13.65M
Revenue (ttm)	25.41M
Net Income (ttm)	-27.50M
Shares Out	11.01M
EPS (ttm)	-3.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	42,679
Open	1.220
Previous Close	1.225
Day's Range	1.220 - 1.255
52-Week Range	1.180 - 4.770
Beta	0.25
Analysts	Strong Buy
Price Target	9.00 (+625.81%)
Earnings Date	May 15, 2025

About LFWD

Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological r...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Sep 12, 2014
• Employees: 80
• Stock Exchange: NASDAQ
• Ticker Symbol: LFWD
• Website: https://golifeward.com

Financial Performance

In 2024, Lifeward's revenue was $25.66 million, an increase of 85.24% compared to the previous year's $13.85 million. Losses were -$28.94 million, 30.8% more than in 2023.

Analyst Forecast

According to 3 analysts, the average rating for LFWD stock is "Strong Buy." The 12-month stock price forecast is $9.0, which is an increase of 625.81% from the latest price.

Price Target

$9.0

(625.81% upside)

Analyst Consensus: Strong Buy